Literature DB >> 19393650

Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.

Gunilla T Westermark1, Per Westermark.   

Abstract

Systemic AA-amyloidosis is a complication of chronic inflammatory diseases and the fibril protein AA derives from the acute phase reactant serum AA. AA-amyloidosis can be induced in mice by an inflammatory challenge. The lag phase before amyloid develops can be dramatically shortened by administration of a small amount of amyloid fibrils. Systemic AA-amyloidosis is transmissible in mice and may be so in humans. Since transmission can cross species barriers it is possible that AA-amyloidosis can be induced by amyloid in food, e.g. foie gras. In mice, development of AA-amyloidosis can also be accelerated by other components with amyloid-like properties. A new possible risk factor may appear with synthetically made fibrils from short peptides, constructed for tissue repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393650     DOI: 10.1016/j.febslet.2009.04.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Prion-like disorders: blurring the divide between transmissibility and infectivity.

Authors:  Mimi Cushman; Brian S Johnson; Oliver D King; Aaron D Gitler; James Shorter
Journal:  J Cell Sci       Date:  2010-04-15       Impact factor: 5.285

Review 2.  Prion-like mechanisms in neurodegenerative diseases.

Authors:  Bess Frost; Marc I Diamond
Journal:  Nat Rev Neurosci       Date:  2009-12-23       Impact factor: 34.870

3.  Tau protein assembles into isoform- and disulfide-dependent polymorphic fibrils with distinct structural properties.

Authors:  Yoshiaki Furukawa; Kumi Kaneko; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

4.  Investigation of the Levels of Serum Amyloid A, YKL-40, and Pentraxin-3 in Patients with Familial Mediterranean Fever.

Authors:  Sefa Ciftci; Huseyin Tugrul Celik; Pinar Atukeren; Nurdan Ciftci; Mustafa Saygin Deniz; Yasemin Coskun Yavuz; Fatmanur Hacievliyagil Kazanci; Sümeyye Gök; Hilmi Demirin; Muhammet Ramazan Yigitoglu
Journal:  J Clin Lab Anal       Date:  2016-05-26       Impact factor: 2.352

5.  Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.

Authors:  N Muhammad; T Murakami; Y Inoshima; N Ishiguro
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

6.  Localized thymic amyloidosis presenting with myasthenia gravis: case report.

Authors:  Seung-Myoung Son; Yong-Moon Lee; Si Wook Kim; Ok-Jun Lee
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153

7.  Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Authors:  Saipraveen Srinivasan; Sanket Patke; Yun Wang; Zhuqiu Ye; Jeffrey Litt; Sunit K Srivastava; Maria M Lopez; Dmitry Kurouski; Igor K Lednev; Ravi S Kane; Wilfredo Colón
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

8.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09

Review 9.  Currents concepts on the immunopathology of amyloidosis.

Authors:  Anupama Bhat; Carlo Selmi; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

10.  Stability of Human Serum Amyloid A Fibrils.

Authors:  Wenhua Wang; Ulrich H E Hansmann
Journal:  J Phys Chem B       Date:  2020-11-16       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.